Aligato, Jay-ar P.

HRN: 22-07-38  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2022
CEFUROXIME 750MG (VIAL)
10/18/2022
10/25/2022
IV
290 Mg
Q8
AGE With Severe Dehydration;RO UTI
Waiting Final Action 
12/13/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/13/2022
12/19/2022
IVT
225mg
Q6
Urti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: